Clinical Trials Directory

Trials / Completed

CompletedNCT02879968

Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

Correlation Between Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
Prince of Songkla University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Correlation between serum squamous cell carcinoma antigen level and tumor volume in Head and Neck Cancer is to determine a correlation between level of serum squamous cell carcinoma antigen and tumor volume in Head and Neck Caner measured by cross-sectional imaging.

Detailed description

The study is a cross-sectional study. A single measurement of serum squamous cell carcinoma antigen level is performed in the eligible Head and Neck squamous cell carcinoma patients. The study tool measuring serum squamous cell carcinoma antigen level is ARCHITECT SCC (Abbott). The gross tumor volume in the cross sectional imaging obtained within 2 weeks of each patient is calculated with the typical ellipsoid formula. Correlation between both parameters will be determined.

Conditions

Interventions

TypeNameDescription
OTHERNon-interventional study

Timeline

Start date
2016-08-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2016-08-26
Last updated
2020-03-04

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02879968. Inclusion in this directory is not an endorsement.